Cite
HARVARD Citation
James, N. et al. (2022). Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). International journal of cancer. 151 (3), pp. 422-434. [Online].